Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Shares of AMN Healthcare Services, Inc. ( AHS - Snapshot Report ) reached a new 52-week high of $7.87 on August 21, and have shot up 35.5% since posting solid second-quarter 2012 results earlier this month. Earnings per share in the quarter soared 266.7% year over year, marking a 57.1% positive earnings surprise.
This healthcare staffing and clinical workforce management solutions provider has outperformed the Zacks Consensus Estimate in 4 out of the last 6 quarters, and delivered in-line results in the other two. The stock now holds a Zacks #1 Rank (Strong Buy) and has surged 80.3% year-to-date, demonstrating its inherent strength and long-term earnings growth projection of 14%.
Fabulous 2Q, Upbeat Guidance
AMN Healthcare Services declared impressive second-quarter results on August 2, wherein earnings of 11 cents per share surpassed the Zacks Consensus Estimate of 7 cents and increased substantially from 3 cents in the prior-year quarter.
The quarters earnings were aided by improving demand and constructive implementation of strategy in its core staffing and recruitment services and workforce solutions. Looking at the earnings surprise trend over the last six quarters, AMN Healthcare Services has topped estimates by an average of 133.1%.
Consolidated sales of $235.8 million comfortably surpassed the Zacks Consensus Estimate of $231 million, and rose 7% year over year. The company experienced sales increases across the Nurse and Allied Healthcare Staffing (up 13%) and Physician Permanent Placement Services segments (up 1%), partly mitigated by a sales decline at Locum Tenens Staffing segment (down 5%). Gross profit jumped 11% to $67 million, whereas gross margin expanded 110 basis points to 28.4%.
Management now expects third quarter consolidated sales between $236 million and $240 million, reflecting a year-over-year growth of 3% to 5%. Gross margin is projected at 28% to 28.5%.
Earnings Momentum Climbing
The Zacks Consensus Estimate for 2012 rose 11.4% to 39 cents per share in the past 30 days, thanks to upward revisions in all 6 estimates. The current estimate implies year-over-year growth of 178.6%.
For 2013, four of 6 estimates were revised higher over the same timeframe, lifting the Zacks Consensus Estimate by 4.3% to 49 cents per share. The current estimate suggests year-over-year growth of 26.5%.
Premium Valuation
AMN Healthcare Services currently trades at a forward P/E of 19.46x, reflecting a 5.4% premium to the peer group average of 18.47x. Also, on a price-to-book basis, shares trade at 2.18x, a 1.9% premium to the peer group average of 2.14x. However, on a price-to-sales basis, the stock trades at 0.33x, indicating a discount of 48.4% to the peer group average of 0.64x.
A Look at the Chart
The chart below indicates that after witnessing volatility in the past, the stock price has now started to correlate with the increasing trend seen in estimates. The year-to-date return for the stock is 80.3% compared to the S&P 500s return of 10.7%.
Founded in 1985 and headquartered in San Diego, California, AMN Healthcare Services offers healthcare recruitment and clinical staff management solutions in the U. S., and operates under three segments Nurse and Allied Healthcare Staffing, Locum Tenens Staffing and Physician Permanent Placement Services. The company provides staffing solutions for hospitals and other healthcare institutions, provides physicians on a temporary and permanent basis, and offers a recruitment process outsourcing program. The company has a market cap of $309.9 million, and competes with Cross Country Healthcare, Inc. (CCRN) and On Assignment Inc. (ASGN).
Read the full reports :
Snapshot Report on AHS